YHEC announced appointment of Stuart Mealing as Associate Director of Health Technology Assessment

August 20, 2017 – Pharmaceutical

YHEC is pleased to announce the appointment of Stuart Mealing as
Associate Director of Health Technology Assessment. Stuart will be
leading the YHEC economic evaluation and modelling team. Stuart has a
Masterís degree in operational research from the University of Lancaster
Business School and a post-graduate certificate in international
business management from Smurfit Business School, Dublin.

Stuart has worked in numerous therapy areas including oncology (solid tumour and haematological), cardiology, pulmonology, ophthalmology and neurology. Stuart has extensive experience in the development and review of cost-effectiveness and budget impact models, and has particular experience in working with medical devices and the modelling of orphan/ultra-orphan conditions.

Before joining YHEC in August 2017, Stuart was the EU Head of Health Economics at ICON Clinical Research Ltd and, before that, worked as a researcher at PenTAG, one of the research groups that performs independent assessments for NICE.

YHECís Director, Matthew Taylor, said:

‘Iím delighted that Stuart has joined our team. He has spent over a decade working on NICE submissions and has a rich wealth of experience to share with our clients. His knowledge of economic evaluation will be an asset to the group, and the staff here are very much looking forward to working with him.’

Address: YHEC, Enterprise House, Innovation Way, University of York, York, YO10 5NQ, United Kingdom